Ian Weissman claims a low cost antidepressant treats long COVID fatigue, while Todd Davenport pushes back that there is not convincing evidence it works, reflecting ongoing uncertainty about pharmacologic options.
A common and low-cost antidepressant can successfully treat fatigue associated with long COVID.
It is one of the first times a medication has been shown to effectively treat the condition.
Honestly it doesn't matter *how* fluvoxamine might work in Long Covid. We don't have convincing evidence *that* it worked.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare